ECSP034682A - ANCIGONISTS OF RECEIVERS OF EXCITATORY AMINO ACIDS - Google Patents

ANCIGONISTS OF RECEIVERS OF EXCITATORY AMINO ACIDS

Info

Publication number
ECSP034682A
ECSP034682A EC2003004682A ECSP034682A ECSP034682A EC SP034682 A ECSP034682 A EC SP034682A EC 2003004682 A EC2003004682 A EC 2003004682A EC SP034682 A ECSP034682 A EC SP034682A EC SP034682 A ECSP034682 A EC SP034682A
Authority
EC
Ecuador
Prior art keywords
ancigonists
receivers
amino acids
excitatory amino
salt
Prior art date
Application number
EC2003004682A
Other languages
Spanish (es)
Inventor
Michael John Martinelli
Vien Van Khau
Michael Edward Letourneau
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of ECSP034682A publication Critical patent/ECSP034682A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Abstract

Una sal farmacéutica mente aceptable de un compuesto de fórmula: (gráfico) o un pro fármaco del mismo en la que la sal farmaceúticamente aceptable se selecciona del grupo constituido por la sal del ácido D-( -)-mandélico o la sal del ácido 1, 5-naftalenodisulfónico.A pharmaceutically acceptable salt of a compound of the formula: (graph) or a pro-drug thereof in which the pharmaceutically acceptable salt is selected from the group consisting of the salt of D- (-) - mandelic acid or the salt of acid 1 , 5-naphthalenedisulfonic acid.

EC2003004682A 2001-01-05 2003-07-03 ANCIGONISTS OF RECEIVERS OF EXCITATORY AMINO ACIDS ECSP034682A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US26001401P 2001-01-05 2001-01-05

Publications (1)

Publication Number Publication Date
ECSP034682A true ECSP034682A (en) 2003-08-29

Family

ID=22987455

Family Applications (1)

Application Number Title Priority Date Filing Date
EC2003004682A ECSP034682A (en) 2001-01-05 2003-07-03 ANCIGONISTS OF RECEIVERS OF EXCITATORY AMINO ACIDS

Country Status (23)

Country Link
EP (1) EP1351955A1 (en)
JP (1) JP2004520335A (en)
KR (1) KR20030066797A (en)
CN (1) CN1484642A (en)
AR (1) AR035679A1 (en)
BR (1) BR0116672A (en)
CA (1) CA2431545A1 (en)
CZ (1) CZ20031856A3 (en)
DZ (1) DZ3460A1 (en)
EA (1) EA200300770A1 (en)
EC (1) ECSP034682A (en)
HR (1) HRP20030544A2 (en)
HU (1) HUP0302528A2 (en)
IL (1) IL156138A0 (en)
MX (1) MXPA03005981A (en)
NO (1) NO20032973L (en)
NZ (1) NZ525821A (en)
PE (1) PE20020792A1 (en)
PL (1) PL361934A1 (en)
SK (1) SK8242003A3 (en)
TW (1) TW591023B (en)
WO (1) WO2002053561A1 (en)
ZA (1) ZA200304311B (en)

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5284957A (en) * 1992-09-03 1994-02-08 Eli Lilly And Company Excitatory amino acid receptor antagonists
EP1053234A1 (en) * 1998-02-06 2000-11-22 Smithkline Beecham Plc Salts of paroxetine
GB9908175D0 (en) * 1999-04-09 1999-06-02 Lilly Co Eli Method of treating neurological disorders
TR200200066T2 (en) * 1999-07-06 2002-04-22 Eli Lilly And Company Selective iGluR5 receptor antagonists for the treatment of migraine

Also Published As

Publication number Publication date
JP2004520335A (en) 2004-07-08
IL156138A0 (en) 2003-12-23
KR20030066797A (en) 2003-08-09
TW591023B (en) 2004-06-11
CA2431545A1 (en) 2002-07-11
MXPA03005981A (en) 2003-09-10
EA200300770A1 (en) 2003-10-30
HRP20030544A2 (en) 2004-08-31
PE20020792A1 (en) 2002-09-06
DZ3460A1 (en) 2002-07-11
PL361934A1 (en) 2004-10-18
EP1351955A1 (en) 2003-10-15
SK8242003A3 (en) 2004-01-08
NO20032973D0 (en) 2003-06-27
NZ525821A (en) 2004-07-30
CN1484642A (en) 2004-03-24
CZ20031856A3 (en) 2003-09-17
NO20032973L (en) 2003-06-27
BR0116672A (en) 2003-09-23
HUP0302528A2 (en) 2003-11-28
WO2002053561A1 (en) 2002-07-11
AR035679A1 (en) 2004-06-23
ZA200304311B (en) 2004-09-02

Similar Documents

Publication Publication Date Title
CO5271657A1 (en) DERIVATIVES OF AZAINDOL
EP1602370A3 (en) Synergistic combinations comprising a renin inhibitor for cardiovascular diseases
HRP20020428B1 (en) Bicyclic amino acids as pharmaceutical agents
RS50140B (en) Percyquinnin, a process for its production, and its use as a pharmaceutical
CY1107146T1 (en) METHODS FOR THE PREVENTION AND TREATMENT OF ALZHEIMER'S DISEASE (AD)
CO5720995A2 (en) NEW COMPOUND
AR051778A2 (en) DERIVATIVES OF DIMETHYLAMINOCROTONIC ACID AND PROCESSES FOR SUPREPARATION
ATE176241T1 (en) 3-AMINO-2-OXO-PIPERIDINEACETIC ACID DERIVATIVES CONTAINING AN ARGININE MIMIMIC COMPOUND WITH ENZYME INHIBITORY EFFECT
AR049274A1 (en) ACID2 - {[2- (2-METHYLAMINOPIRIMIDIN-4-IL) -1H-INDOL-5-CARBONYL] AMINO} -3- (PHENYLPIRIDIN-2-ILAMINO) SUBSTANTIALLY PURE PROPIONIC AS A SELECTIVE KINASE IKK-2 INHIBITOR
AR025307A1 (en) SUSTAINED RELEASE COMPOSITE OF A PEPTIDE, MICROPARTICLES, PHARMACEUTICAL COMPOSITION AND THE USE OF SUCH COMPOUND FOR THE MANUFACTURE OF A MEDICINAL PRODUCT
CY1120408T1 (en) IMPROVED PHARMACEUTICAL FORMS
BR0002073A (en) Process for the preparation of a chiral compound
CO5280222A1 (en) PHARMACEUTICAL COMPOSITION THAT PEMETREXED INCLUDES
DE60027144D1 (en) Hydroxamic acid derivatives
MY133507A (en) New peroxy-carboxylic acid and aqueous compositions thereof
IT1319234B1 (en) GABAPENTINA PREPARATION PROCESS.
BR9913670B1 (en) process for the preparation of a salt of an aliphatic carboxylic acid compound.
ES2190422T3 (en) SELECTIVE ANTAGONISTS OF ADENOSINE A2B RECEPTORS.
DE69327890T2 (en) Process for the preparation of 2- (un) substituted 4-alkylimidazoles
ES2422081T3 (en) Peptide Ser-Ser-Ser-Arg and its medicinal uses
BR0212772A (en) Process for the preparation of repaglinide
DE60129442D1 (en) Sulphonic acid derivates of hydroxyacrylic acids and their use in medicinal products
ECSP034682A (en) ANCIGONISTS OF RECEIVERS OF EXCITATORY AMINO ACIDS
SE9902364D0 (en) New process
BR0110549A (en) Process for the preparation of alkaline earth metal salts of d-pantothenic acid